Jian Xin Yang
Fortune : 13 M $ au 30/06/2026
Fortune : 13 M $ au 30/06/2026
Jian Xin Yang is currently Chief Executive Officer & Executive Director at CStone Pharmaceuticals Co. Ltd. since 2022, with employment at the company starting in 2016.
Former roles include Medical Director at Labcorp Drug Development, Inc. from 2011 to 2014, and Senior VP & Head-Clinical Development at BeOne Medicines Ltd. from 2014 to 2016.
Education includes a graduate degree from Nanjing Medical University conferred in 1988 and an undergraduate degree from Hubei University of Science & Technology conferred in 1985.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/07/2026 | 21 437 683 ( 1,34% ) | 13 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CSTONE PHARMACEUTICALS | Directeur Général | 25/08/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| BEIGENE LTD | Directeur Technique/Scientifique/R&D | 01/12/2016 |
| COVANCE INC. | Directeur Technique/Scientifique/R&D | 01/07/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
Nanjing Medical University
Nanjing Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hubei University of Science & Technology
Hubei University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
CStone Pharmaceuticals Co. Ltd.
CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national